Association of Performance on Olfactory and Cognitive Screening Tests With Conversion to Dementia in a Biracial Cohort of Older Adults
- PMID: 37414570
- PMCID: PMC10491446
- DOI: 10.1212/WNL.0000000000207578
Association of Performance on Olfactory and Cognitive Screening Tests With Conversion to Dementia in a Biracial Cohort of Older Adults
Abstract
Background and objectives: Odor identification deficits are associated with transition to dementia, whereas intact odor identification and global cognition test performance may identify lack of transition. The purpose of this study was to examine intact odor identification and global cognition as prognostic indicators of lack of transition to dementia in a biracial (Black and White) cohort.
Methods: In a community-dwelling sample of older adults from the Health, Aging, and Body Composition study, odor identification was measured using the Brief Smell Identification Test (BSIT), and global cognition was measured using the Teng Modified Mini-Mental State Examination (3MS). Survival analyses for dementia transition over 4 and 8 years of follow-up used Cox proportional hazards models.
Results: A total of 2,240 participants had an average age of 75.5 years (SD 2.8). Approximately 52.7% were female individuals. Approximately 36.7% were Black and 63.3% were White individuals. Impaired odor identification (hazard ratio [HR] 2.29, 95% CI 1.79-2.94, p < 0.001) and global cognition (HR 3.31, 95% CI 2.26-4.84, p < 0.001) were each independently associated with transition to dementia (n = 281). Odor identification remained robustly associated with transition to dementia for Black (HR 2.02, 95% CI 1.36-3.00, p < 0.001, n = 821) and White participants (HR 2.45, 95% CI 1.77-3.38, p < 0.001, n = 1,419), whereas global cognition was associated with transition among Black participants only (HR 5.06, 95% CI 3.18-8.07, p < 0.001). ApoE genotype was consistently associated with transition among White participants only (HR 1.75, 95% CI 1.20-2.54, p < 0.01). Among participants with intact performance on both odor identification (BSIT ≥9/12 correct) and global cognition (3MS ≥ 78/100 correct), 8.8% transitioned to dementia over 8 years. Intact performance on both measures had high positive predictive value for identifying individuals who did not transition to dementia over 4 years (0.98 for ages 70-75 years with only 2.3% transitioning, 0.94 for ages 76-82 years with only 5.8% transitioning).
Discussion: Odor identification testing paired with a global cognitive screening test identified individuals at low risk of transition to dementia in a biracial community cohort with a pronounced effect in the eighth decade of life. Identification of such individuals can reduce the need for extensive investigation to establish a diagnosis. Odor identification deficits showed utility in both Black and White participants, unlike the race-dependent utility of a global cognitive test and ApoE genotype.
© 2023 American Academy of Neurology.
Conflict of interest statement
J.N. Motter, J. Choi, S. Lee, T.E. Goldberg, and S.M. Albert report no disclosures relevant to the manuscript. D.P. Devanand has been a scientific adviser to Acadia, Eisai, Genentech, Jazz, TauRx, Novo Nordisk, and Biogen. Go to
Figures


Similar articles
-
Comparison of brief olfactory and cognitive assessments to neuroimaging biomarkers in the prediction of cognitive decline and dementia in the MCSA cohort.Alzheimers Dement. 2024 Dec;20(12):8346-8358. doi: 10.1002/alz.14261. Epub 2024 Oct 10. Alzheimers Dement. 2024. PMID: 39387454 Free PMC article.
-
Intact global cognitive and olfactory ability predicts lack of transition to dementia.Alzheimers Dement. 2020 Feb;16(2):326-334. doi: 10.1016/j.jalz.2019.08.200. Epub 2020 Jan 4. Alzheimers Dement. 2020. PMID: 31676234 Free PMC article.
-
Olfaction and risk of dementia in a biracial cohort of older adults.Neurology. 2017 Jan 31;88(5):456-462. doi: 10.1212/WNL.0000000000003558. Epub 2016 Dec 30. Neurology. 2017. PMID: 28039314 Free PMC article.
-
Odor identification deficit as a predictor of five-year global cognitive change: interactive effects with age and ApoE-epsilon4.Behav Genet. 2009 Sep;39(5):496-503. doi: 10.1007/s10519-009-9289-5. Epub 2009 Jul 25. Behav Genet. 2009. PMID: 19633944
-
Olfactory Identification Deficits, Cognitive Decline, and Dementia in Older Adults.Am J Geriatr Psychiatry. 2016 Dec;24(12):1151-1157. doi: 10.1016/j.jagp.2016.08.010. Epub 2016 Aug 17. Am J Geriatr Psychiatry. 2016. PMID: 27745824 Free PMC article. Review.
Cited by
-
Olfaction and Plasma Biomarkers of Alzheimer Disease and Neurodegeneration in the Atherosclerosis Risk in Communities Study.Neurology. 2025 Jun 10;104(11):e213706. doi: 10.1212/WNL.0000000000213706. Epub 2025 May 15. Neurology. 2025. PMID: 40373252
-
Characterizing the olfaction and dementia association in the community-based ARIC study.Alzheimers Dement. 2025 Feb;21(2):e14613. doi: 10.1002/alz.14613. Alzheimers Dement. 2025. PMID: 39988999 Free PMC article.
-
Olfactory dysfunction increases progression to dementia in cognitively impaired older adults: a 12-year population-based study.Geroscience. 2025 May 28. doi: 10.1007/s11357-025-01705-7. Online ahead of print. Geroscience. 2025. PMID: 40437282
-
Comparison of brief olfactory and cognitive assessments to neuroimaging biomarkers in the prediction of cognitive decline and dementia in the MCSA cohort.Alzheimers Dement. 2024 Dec;20(12):8346-8358. doi: 10.1002/alz.14261. Epub 2024 Oct 10. Alzheimers Dement. 2024. PMID: 39387454 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous